Breathe Well Live Well
|
Local Student Redesigns The Asthma Inhaler
CBS Local PHILADELPHIA (CBS) – Asthma inhalers haven't changed much over the decades, but a Drexel student has come up with a way that could revolutionize how people manage the disease. Step one: redesign the inhaler. “I wanted to make sure to slim it down … |
View full post on asthma – Google News
|
An asthma inhaler and app designed from the patient's point of view
MedCity News Misplace your inhaler lately? Are you due for a refill? Staying away from spots that exacerbate your asthma? A senior at Drexel University re-imagined an asthma inhaler with a companion app so users can keep a personal record of the quality of their … |
View full post on asthma – Google News
|
Phase III studies show tiotropium delivered via Respimat inhaler proves …
News-Medical.net Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities. These data were presented at … |
View full post on asthma – Google News
|
Teva snags an EU recommendation for its asthma, COPD inhaler
FierceDrugDelivery European regulatory authorities gave Teva ($TEVA) a positive opinion for its DuoResp Spiromax inhalation powder, designed to treat asthma and chronic obstructive pulmonary disease (COPD). With the recommendation from the Committee for Medicinal … |
View full post on asthma – Google News
|
FDA Panels: Primatene HFA Inhaler Not Recommended for Asthma
Medscape "Many of the patients that come to tell me that they have asthma don't have asthma and would be using this product, and probably would be using it every day," Dr. Paasche-Orlow explained. E004 was intended to replace the OTC inhaler epinephrine metered … |
View full post on asthma – Google News
|
OTC asthma inhaler endangers patients by encouraging substandard treatment
News-Medical.net An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit … Seasons change, so do asthma triggers |
View full post on asthma – Google News
|
Proposed Asthma Inhaler Puts Patients at Risk
PR Newswire (press release) VIENNA, Va., Feb. 19, 2014 /PRNewswire-USNewswire/ — An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX; Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified February 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Beclomethasone dipropionate; Drug: Placebo; Drug: albuterol/salbutamol 90 mcg
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified January 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Beclomethasone dipropionate; Drug: Placebo; Drug: Albuterol/salbutamol
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified January 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days